Marc Tordjeman, PhD

started Biocentric, a French Biotech company that is now part of Bruker Microbiology and Diagnostics. In 2005, resulting from a collaborative work with the French National AIDS Research Agency (ANRS), a commercial, reliable, and affordable HIV viral load on open PCR platform was launched with the objective to give low resource-countries access to HIV viral load.